Publication | Closed Access

Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies

Cell TherapyCancer ImmunosurveillanceImmunologyLong-term CulturesAutoimmunityInterleukin-15 Supports GenerationHematological MalignanciesImmunotherapyMedicineRadiation OncologyNatural Killer CellsTumor Microenvironment